These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1925903)

  • 1. Improved methods in long term venous access using the P.A.S. Port.
    Pearl JM; Goldstein L; Ciresi KF
    Surg Gynecol Obstet; 1991 Oct; 173(4):313-5. PubMed ID: 1925903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Central venous access devices in treatment of patients with malignant tumors: venous port, central venous catheter and Hickman catheter. Cost-benefit analysis based on a critical review of the literature, personal experiences with 135 port implantations and patient attitude].
    Krupski G; Fröschle GW; Weh FJ; Schlosser GA
    Chirurg; 1995 Mar; 66(3):202-7. PubMed ID: 7750390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seat belt associated central line fracture--a previously unreported complication in cystic fibrosis.
    Ghayyda SN; Roland D; Cade A
    J Cyst Fibros; 2008 Sep; 7(5):448-9. PubMed ID: 18455967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experiences with a modified implantation technique of Port-A-Cath systems as continuous venous access in infants and children].
    Erhard J; Lange R; Kremens B; Krause U; Eigler FW
    Med Klin (Munich); 1991 Oct; 86(10):512-4. PubMed ID: 1758373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventional radiology in the provision and maintenance of long-term central venous access.
    Lyon SM; Given M; Marshall NL
    J Med Imaging Radiat Oncol; 2008 Feb; 52(1):10-7. PubMed ID: 18373820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Insertion and management of long-term central venous devices: role of radiologic imaging techniques].
    Capaccioli L; Nistri M; Distante V; Rontini M; Manetti A; Stecco A
    Radiol Med; 1998 Oct; 96(4):369-74. PubMed ID: 9972217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing concepts in long-term central venous access: catheter selection and cost savings.
    Horattas MC; Trupiano J; Hopkins S; Pasini D; Martino C; Murty A
    Am J Infect Control; 2001 Feb; 29(1):32-40. PubMed ID: 11172316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fully implantable catheter systems. Long-term results--complications].
    Wenke K; Markewitz A
    Fortschr Med; 1990 May; 108(14):276-9. PubMed ID: 2115492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients.
    Ross MN; Haase GM; Poole MA; Burrington JD; Odom LF
    Surg Gynecol Obstet; 1988 Aug; 167(2):141-4. PubMed ID: 3400032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness and indications for Port-a-Cath in children with acute leukemia].
    Parri FJ; Rovira J; Sancho MA; Julia V; Albert A; Morales L
    Cir Pediatr; 1989 Apr; 2(2):61-3. PubMed ID: 2485670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future dimensions in vascular access--peripheral implantable ports.
    McKee J
    J Intraven Nurs; 1991; 14(6):387-93. PubMed ID: 1748920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A fully implantable port system for venous access. Personal experience with 91 patients].
    Zák P; Tauchman M; Maisnar V; Podzimek K; Mirová S; Voglová J; Dulícek P; Filip S; Chrobák L
    Vnitr Lek; 1997 May; 43(5):273-8. PubMed ID: 9601848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma].
    Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA
    Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complications of the use of implantable reservoirs of central venous access++ in pediatrics: causes and treatment].
    Pérez Martínez A; Martínez Ibáñez V; Ezzedine M
    Cir Pediatr; 1993 Apr; 6(2):59-62. PubMed ID: 8357723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term venous access using a subcutaneous implantable drug delivery system.
    Soo KC; Davidson TI; Selby P; Westbury G
    Ann R Coll Surg Engl; 1985 Jul; 67(4):263-5. PubMed ID: 4037644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term central venous lines and their complications].
    Teichgräber UK; Gebauer B; Benter T; Wagner J
    Rofo; 2004 Jul; 176(7):944-52. PubMed ID: 15237335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Placing central lines in patients with implantable (port-a-cath) systems].
    Tornero Tornero JC; Gomar Sancho C
    Rev Esp Anestesiol Reanim; 2002 Dec; 49(10):561-2. PubMed ID: 12677981
    [No Abstract]   [Full Text] [Related]  

  • 18. Our experience with the Port-A-Cath system.
    Perry B
    AARN News Lett; 1988 Mar; 44(3):25-7. PubMed ID: 3358325
    [No Abstract]   [Full Text] [Related]  

  • 19. Do central venous catheters have advantages over arteriovenous fistulas or grafts?
    Quarello F; Forneris G; Borca M; Pozzato M
    J Nephrol; 2006; 19(3):265-79. PubMed ID: 16874685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fluid dynamics in the Port-a-Cath Low Profile: therapeutic uses].
    Perez Martínez A; Escribano Garaizábal E; Goñi Orayen C; Marco Macián A; Gonzálvez Piñera J; Moya Marchante M
    Cir Pediatr; 1994 Oct; 7(4):192-5. PubMed ID: 7865365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.